CRIS Q1 2023 Earnings — Curis, Inc. Revenue & Financial Results | Market Cap Arena

CRISCuris, Inc.

$15M

Q1 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M+11.7% YoY

Gross Profit

$2M99.0% margin

Operating Income

-$12M-506.2% margin

Net Income

-$12M-503.2% margin

EPS (Diluted)

$-2.38

QoQ Revenue Growth

-20.4%

Cash Flow

Operating Cash Flow

-$12M

Free Cash Flow

-$12M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$95M

Total Liabilities

$58M

Stockholders' Equity

$37M

Cash & Equivalents

$32M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$2M	+11.7%
Gross Profit	$2M	$2M	+15.1%
Operating Income	-$12M	-$15M	+23.2%
Net Income	-$12M	-$16M	+28.2%

Revenue Segments

Gross Royalty Revenue

$2M100%